Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bifidogenic Effect of 2′-Fucosyllactose (2′-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical Trial

11 Mar 2025

Abstract excerpt

Breast milk is rich in bioactive components, especially human milk oligosaccharides (HMOs), which are crucial for establishing gut microbiota. The 2′-FL (2-Fucosyllactose), one of the most abundant oligosaccharides in breast milk, functions as a selective prebiotic. Objective: To examine the effect of adding 2′-FL (2-Fucosyllactose) to an infant formula containing prebiotic galacto-oligosaccharides (GOSs) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breastfeeding Practices and Influences
Share to Infant Nutrition and Health
Share to Pediatric health and respiratory diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40290019
DOI: 10.3390/nu17060973

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bifidogenic Effect of 2′-Fucosyllactose (2′-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical TrialPMID 40290019Read ↗

Term Infant Formula Supplemented with Human Milk Oligosaccharides (2′Fucosyllactose and Lacto‐N‐ neo tetraose) Shifts Stool Microbiota and Metabolic Signatures Closer to that of Breastfed InfantsSemantic proximity Read ↗

Effects of addition of 2-fucosyllactose to infant formula on growth and specific pathways of utilization by Bifidobacterium in healthy term infantsSemantic proximity Read ↗

Genomic analysis of cultivated infant microbiomes identifies Bifidobacterium 2’-fucosyllactose utilization can be facilitated by co-existing speciesSemantic proximity Read ↗

Human Milk Oligosaccharides: 2’-fucosyllactose (2’-FL) and Lacto-N-neotetraose (LNnT) in Infant FormulaSemantic proximity Read ↗

Genomic analysis of cultivated infant microbiomes identifies <i>Bifidobacterium</i> 2’-fucosyllactose utilization can be facilitated by co-existing speciesSemantic proximity Read ↗

Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensalSemantic proximity Read ↗

Mutualistic interactions between Escherichia coli and Bifidobacterium bifidum enable degradation of human milk oligosaccharides in healthy infantsSemantic proximity Read ↗

Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiotaSemantic proximity Read ↗

Immunomodulatory and Prebiotic Effects of 2′-Fucosyllactose in Suckling RatsSemantic proximity Read ↗

Longitudinal changes of human milk oligosaccharides, breastmilk microbiome and infant gut microbiome are associated with maternal characteristicsSemantic proximity Read ↗

Effects of Human Milk Oligosaccharides in Infant Health Based on Gut Microbiota AlterationSemantic proximity Read ↗

Human Milk Oligosaccharides (HMOs) and Infant Microbiota: A Scoping ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.